|
|
|
A conversation with Judy Chou, Ph.D., AltruBio | AltruBio's CEO has a rough map of the steps to distributed cell therapy manufacturing. She discusses the path and some of the obstacles we'll need to clear first. | |
|
|
|
|
|
| Optimizing And Scaling Lentiviral Vector Production | Application Note | MilliporeSigma | Here, we outline how the upstream and downstream workflows of the VirusExpress® platform for lentiviral vectors were optimized through the use of design of experiments and supplementary studies. |
|
|
|
| A Non-Viral Workflow For Modifying Primary T Cells | Application Note | By Boon Hwa Neo, Samatha Bandapalle, Joseph O’Connor, et al., Lonza | This study demonstrates the ability of combined platforms with complimentary technologies to modify primary T cells in a functionally-closed, automated fashion. |
|
|
| Data-Driven CHO Bioprocess Optimization And Scale-Up | Application Note | 908 Devices | Learn how at-line cell culture media analysis enhances mAb production by refining nutrient feed strategies, reducing toxic metabolites, and improving yields while lowering costs. |
|
|
|
|
|
|
|
|
Connect With Cell & Gene: |
|
|
|